Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene.

PubWeight™: 2.36‹?› | Rank: Top 2%

🔗 View Article (PMC 265164)

Published in J Clin Microbiol on April 01, 1992

Authors

C A Gaydos1, T C Quinn, J J Eiden

Author Affiliations

1: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Articles citing this

Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93

Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study. J Clin Microbiol (1999) 3.56

Elimination of contaminating DNA within polymerase chain reaction reagents: implications for a general approach to detection of uncultured pathogens. J Clin Microbiol (1993) 3.22

Discrimination among thermophilic Campylobacter species by polymerase chain reaction amplification of 23S rRNA gene fragments. J Clin Microbiol (1993) 2.54

Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory. Clin Microbiol Rev (1997) 2.11

Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol (1996) 1.68

Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells. J Clin Microbiol (2000) 1.63

Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae. J Clin Microbiol (2002) 1.61

Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol (2000) 1.60

Molecular diagnosis of Chlamydia pneumoniae infection. J Clin Microbiol (1999) 1.52

Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol (2001) 1.46

Chlamydia pneumoniae. Thorax (1993) 1.40

A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol (2010) 1.39

Chlamydia pneumoniae infection in human monocytes. Infect Immun (1999) 1.28

Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene. Infect Immun (1992) 1.19

Comparison of sample preparation methods for detection of Chlamydia pneumoniae in bronchoalveolar lavage fluid by PCR. J Clin Microbiol (1994) 1.17

Determination of PCR efficiency in chelex-100 purified clinical samples and comparison of real-time quantitative PCR and conventional PCR for detection of Chlamydia pneumoniae. BMC Microbiol (2002) 1.16

Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol (1994) 1.15

Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay. J Clin Microbiol (1998) 1.09

Comparison of an industry-derived LCx Chlamydia pneumoniae PCR research kit to in-house assays performed in five laboratories. J Clin Microbiol (2002) 1.09

Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol (2005) 1.08

Chlamydial respiratory infections. BMJ (1993) 1.06

Detection of the Bacillus anthracis gyrA gene by using a minor groove binder probe. J Clin Microbiol (2004) 1.06

Use of lambda phage DNA as a hybrid internal control in a PCR-enzyme immunoassay to detect Chlamydia pneumoniae. J Clin Microbiol (1998) 1.02

Development and evaluation of Chlamylege, a new commercial test allowing simultaneous detection and identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in clinical respiratory specimens by multiplex PCR. J Clin Microbiol (2005) 1.01

Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol (2000) 0.98

Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice. Antimicrob Agents Chemother (2005) 0.96

Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR. Eur J Clin Microbiol Infect Dis (2003) 0.92

Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study. J Korean Med Sci (2006) 0.91

Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients. Eur J Clin Microbiol Infect Dis (2006) 0.89

Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern. BMC Infect Dis (2007) 0.88

PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids. Clin Diagn Lab Immunol (2001) 0.85

Is the perceived association between Chlamydia pneumoniae and vascular diseases biased by methodology? J Clin Microbiol (2004) 0.84

Identification of selected respiratory pathogens in endodontic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 0.82

Chlamydial and periodontal pathogens induce hepatic inflammation and fatty acid imbalance in apolipoprotein E-deficient mice. Infect Immun (2009) 0.81

Phylogenetic analyses of Chlamydia psittaci strains from birds based on 16S rRNA gene sequence. J Clin Microbiol (1997) 0.80

Laboratory diagnosis of Chlamydia pneumoniae infections. Can J Infect Dis (1995) 0.80

Culture-negative endocarditis due to Chlamydia pneumoniae. J Clin Microbiol (2002) 0.78

No correlation between giant cell arteritis and Chlamydia pneumoniae infection: investigation of 189 patients by standard and improved PCR methods. J Clin Microbiol (2009) 0.78

Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia. J Neurol (2007) 0.76

Nucleic acid sequence citations: need for more-specific guidelines. J Clin Microbiol (1993) 0.75

Articles cited by this

Bacterial evolution. Microbiol Rev (1987) 85.63

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03

A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 6.52

Eubacterial origin of chlamydiae. J Bacteriol (1986) 4.47

Specific amplification of a DNA sequence common to all Chlamydia trachomatis serovars using the polymerase chain reaction. Res Microbiol (1989) 4.38

Comparison between DNA melting thermodynamics and DNA polymerase fidelity. Proc Natl Acad Sci U S A (1988) 4.07

Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA (1991) 3.99

Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay. J Clin Microbiol (1990) 3.80

Diagnostic value of the polymerase chain reaction for Chlamydia detection as determined in a follow-up study. J Clin Microbiol (1991) 3.27

Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00

Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78

An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis (1985) 2.60

Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis (1991) 2.35

Three new serovars of Chlamydia trachomatis: Da, Ia, and L2a. J Infect Dis (1991) 2.26

Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis (1988) 2.15

Detection and differentiation of Chlamydia trachomatis, Chlamydia psittaci, and Chlamydia pneumoniae by DNA amplification. J Infect Dis (1990) 1.98

Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test. J Clin Microbiol (1979) 1.96

Direct sequence evaluation of the major outer membrane protein gene variant regions of Chlamydia trachomatis subtypes D', I', and L2'. Infect Immun (1991) 1.89

Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch Intern Med (1989) 1.86

A polymerase chain reaction (PCR) protocol for the specific detection of Chlamydia spp. Mol Cell Probes (1989) 1.74

Antigenic variation among strains of Chlamydia pneumoniae. J Clin Microbiol (1991) 1.51

Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease. J Pediatr (1991) 1.30

Experimental infection with Chlamydia pneumoniae in nonhuman primates. Infect Immun (1990) 1.13

Culture-confirmed pneumonia due to Chlamydia pneumoniae. J Infect Dis (1991) 1.10

Articles by these authors

(truncated to the top 100)

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68

Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet (1999) 10.28

HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet (1997) 7.52

Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol (1993) 6.21

AIDS in Africa: an epidemiologic paradigm. Science (1986) 5.88

Sex differences in HIV-1 viral load and progression to AIDS. Lancet (1998) 5.24

Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1994) 5.15

Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS (2000) 5.14

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med (1999) 5.05

Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85

Chlamydia trachomatis infections in female military recruits. N Engl J Med (1998) 4.68

Azithromycin in control of trachoma. Lancet (1999) 4.32

Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23

Spread of HIV infection in married monogamous women in India. JAMA (1997) 4.18

Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA (1998) 4.12

Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection. Ann Intern Med (1982) 3.95

Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med (1997) 3.71

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69

A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54

Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50

Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol (1995) 3.44

Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA (2001) 3.41

Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India. BMJ (1995) 3.38

Field testing and comparative evaluation of rapid, visually read screening assays for antibody to human immunodeficiency virus. Lancet (1989) 3.18

Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions. A multicenter trial. Ann Intern Med (1984) 3.15

The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12

Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02

Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol (1998) 2.81

Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol (2000) 2.80

Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med (1998) 2.78

Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69

Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med (2001) 2.68

Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65

Evidence for high prevalence & rapid transmission of HIV among individuals attending STD clinics in Pune, India. Indian J Med Res (1996) 2.64

NIH conference. Gastrointestinal infections in AIDS. Ann Intern Med (1992) 2.62

Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis (1998) 2.60

The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India. Sex Transm Dis (1999) 2.57

Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun (1996) 2.52

Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet (1984) 2.43

Hepatitis B and hepatitis C in emergency department patients. N Engl J Med (1992) 2.39

Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol (1998) 2.35

Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing. Ann Emerg Med (1999) 2.31

Epidemiology of hepatitis E virus infection in Turkey. Lancet (1993) 2.29

Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet (1998) 2.29

Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis (1992) 2.25

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection. J Infect Dis (2000) 2.25

The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24

Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol (1997) 2.22

In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. Antimicrob Agents Chemother (1987) 2.21

Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA (1994) 2.18

Unsuspected human immunodeficiency virus in critically ill emergency patients. JAMA (1987) 2.17

Evidence for HTLV-III infection in prostitutes in Tamil Nadu (India). Indian J Med Res (1987) 2.13

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis (1996) 2.12

Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA (1994) 2.11

Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Microbiol (1992) 2.09

Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Rev Infect Dis (1989) 2.09

The human immunodeficiency virus epidemic in India. Current magnitude and future projections. Medicine (Baltimore) (1995) 2.09

Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol (1998) 2.07

Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol (2000) 2.05

Risk factors and clinical presentation of acute primary HIV infection in India. JAMA (1997) 2.02

Detection and differentiation of Chlamydia trachomatis, Chlamydia psittaci, and Chlamydia pneumoniae by DNA amplification. J Infect Dis (1990) 1.98

Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA (1987) 1.98

Herpes simplex virus proctitis in homosexual men. Clinical, sigmoidoscopic, and histopathological features. N Engl J Med (1983) 1.97

Enzyme-linked immunosorbent assay for the detection of Giardia lamblia in fecal specimens. J Infect Dis (1984) 1.93

Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology (1988) 1.93

Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis (1995) 1.86

Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med (1984) 1.85

Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis (1998) 1.83

Condom use and HIV infection among prostitutes in Zaire. N Engl J Med (1987) 1.82

Screening for Chlamydia trachomatis infection in an inner-city population: a comparison of diagnostic methods. J Infect Dis (1985) 1.81

Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis (1994) 1.78

Substantial increase in human immunodeficiency virus (HIV-1) infection in critically ill emergency patients: 1986 and 1987 compared. Ann Emerg Med (1989) 1.78

Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun (1992) 1.77

Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med (1993) 1.76

Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis (1997) 1.74

Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73

Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol (1993) 1.73

Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol (2001) 1.72

Intestinal spirochetosis in homosexual men. Am J Med (1987) 1.72

Unsuspected gonorrhea and chlamydia in patients of an urban adult emergency department: a critical population for STD control intervention. Sex Transm Dis (2001) 1.70

Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis (2001) 1.66

Characterization of patients accepting and refusing routine, voluntary HIV antibody testing in public sexually transmitted disease clinics. Sex Transm Dis (1994) 1.63

Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol (2000) 1.60

Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens. J Clin Microbiol (1990) 1.59

Postabortal endometritis and isolation of Chlamydia trachomatis. Obstet Gynecol (1986) 1.58

Screening for gonorrhea and chlamydia by DNA amplification in adolescents attending middle school health centers. Opportunity for early intervention. Sex Transm Dis (1998) 1.58

Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Chest (1998) 1.57

In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother (1992) 1.56

A clinical and pathological comparison of the WHO and CDC case definitions for AIDS in Kinshasa, Zaïre: is passive surveillance valid? AIDS (1993) 1.55

HIV seroprevalence among hospital workers in Kinshasa, Zaire. Lack of association with occupational exposure. JAMA (1986) 1.54

Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol (1989) 1.54

Preference among female Army recruits for use of self-administrated vaginal swabs or urine to screen for Chlamydia trachomatis genital infections. Sex Transm Dis (2003) 1.53

Interaction of tryptophan transfer RNA with Rous sarcoma virus 35S RNA. Nature (1976) 1.53

Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.53

Molecular diagnosis of Chlamydia pneumoniae infection. J Clin Microbiol (1999) 1.52